Fluorescence resonance energy transfer-based assay for characterization of hepatitis C virus NS3-4A protease activity in live cells

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 2, 2009, Pages 728-734

  Sabariegos, Rosario ^a   Picazo, Fernando ^a   Domingo, Beatriz ^a   Franco, Sandra ^b   Martinez, Miguel Angel ^b   Llopis, Juan ^a  

^a University of Castilla La Mancha   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYAN FLUORESCENT PROTEIN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; PROTEINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SPECTROFLUOROMETRY; VIRUS CHARACTERIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CATALYSIS; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HEPACIVIRUS; HUMANS; PLASMIDS; SPECTROMETRY, FLUORESCENCE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 59749089747     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01029-08     Document Type: Article

References (33)

1. Breiman, A., D. Vitour, M. Vilasco, C. Ottone, S. Molina, L. Pichard, C. Fournier, D. Delgrange, P. Charneau, G. Duverlie, C. Wychowski, P. Maurel, and E. F. Meurs. 2006. A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells. J. Gen. Virol. 87:3587-3598.
2. Carrat, F., F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, A. Benzekri, P. Morand, C. Goujard, G. Pialoux, L. Piroth, D. Salmon-Ceron, C. Degott, P. Cacoub, and C. Perronne. 2004. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292:2839-2848.
3. Chen, H., H. L. Puhl III, S. V. Koushik, S. S. Vogel, and S. R. Ikeda. 2006. Measurement of FRET efficiency and ratio of donor to acceptor concentration in living cells. Biophys. J. 91:L39-L41.
4. Dimasi, N., A. Pasquo, F. Martin, M. S. Di, C. Steinkuhler, R. Cortese, and M. Sollazzo. 1998. Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein. Protein Eng. 11:1257-1265.
5. Domingo, B., R. Sabariegos, F. Picazo, and J. Llopis. 2007. Imaging FRET standards by steady-state fluorescence and lifetime methods. Microsc. Res. Tech. 70:1010-1021.
6. Forster, T. 1948. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann. Physik 2:55-75.
7. Franco, S., B. Clotet, and M. A. Martinez. 2008. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. Virus Res. 131:260-270.
8. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:2832-2843.
9. He, Y., M. S. King, D. J. Kempf, L. Lu, H. B. Lim, P. Krishnan, W. Kati, T. Middleton, and A. Molla. 2008. Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system. Antimicrob. Agents Chemother. 52:1101-1110.
10. Heim, R., and R. Y. Tsien. 1996. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr. Biol. 6:178-182.
11. Hsu, Y. Y., Y. N. Liu, W. Wang, F. J. Kao, and S. H. Kung. 2007. In vivo dynamics of enterovirus protease revealed by fluorescence resonance emission transfer (FRET) based on a novel FRET pair. Biochem. Biophys. Res. Commun. 353:939-945.
12. Hu, K., J. F. Clement, L. Abrahamyan, K. Strebel, M. Bouvier, L. Kleiman, and A. J. Mouland. 2005. A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer. J. Virol. Methods 128:93-103.
13. Katayama, H., A. Yamamoto, N. Mizushima, T. Yoshimori, and A. Miyawaki. 2008. GFP-like proteins stably accumulate in lysosomes. Cell Struct. Funct. 33:1-12.
14. Konstantinidis, A. K., P. L. Richardson, K. A. Kurtz, R. Tripathi, C. M. Chen, P. Huang, J. Randolph, D. Towne, J. Donnelly, U. Warrior, T. Middleton, and W. M. Kati. 2007. Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease. Anal. Biochem. 368:156-167.
15. Lee, J. C., C. F. Chang, Y. H. Chi, D. R. Hwang, and J. T. Hsu. 2004. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells. J. Virol. Methods 116:27-33.
16. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
17. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
18. Lu, L., T. J. Pilot-Matias, K. D. Stewart, J. T. Randolph, R. Pithawalla, W. He, P. P. Huang, L. L. Klein, H. Mo, and A. Molla. 2004. Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro. Antimicrob. Agents Chemother. 48:2260-2266.
19. Mao, S. S., J. DiMuzio, C. McHale, C. Burlein, D. Olsen, and S. S. Carroll. 2008. A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations. Anal. Biochem. 373:1-8.
20. Martinez, M. A., and B. Clotet. 2003. Genetic screen for monitoring hepatitis C virus NS3 serine protease activity. Antimicrob. Agents Chemother. 47:1760-1765.
21. Mitra, R. D., C. M. Silva, and D. C. Youvan. 1996. Fluorescence resonance energy transfer between blue-emitting and red-shifted excitation derivatives of the green fluorescent protein. Gene 173:13-17.
22. Pacini, L., L. Bartholomew, A. Vitelli, and G. Migliaccio. 2004. Reporter substrates for assessing the activity of the hepatitis C virus NS3-4A serine protease in living cells. Anal. Biochem. 331:46-59.
23. Pawlotsky, J. M., S. Chevaliez, and J. G. McHutchison. 2007. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 132:1979-1998.
24. Perni, R. B., S. J. Almquist, R. A. Byrn, G. Chandorkar, P. R. Chaturvedi, L. F. Courtney, C. J. Decker, K. Dinehart, C. A. Gates, S. L. Harbeson, A. Heiser, G. Kalkeri, E. Kolaczkowski, K. Lin, Y. P. Luong, B. G. Rao, W. P. Taylor, J. A. Thomson, R. D. Tung, Y. Wei, A. D. Kwong, and C. Lin. 2006. Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease. Antimicrob. Agents Chemother. 50:899-909.
25. Reesink, H. W., S. Zeuzem, C. J. Weegink, N. Forestier, A. van Vliet, J. van de Wetering de Rooij, L. McNair, S. Purdy, R. Kauffman, J. Alam, and P. L. Jansen. 2006. Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. Gastroenterology 131:997-1002.
26. Sarrazin, C., R. Rouzier, F. Wagner, N. Forestier, D. Larrey, S. K. Gupta, M. Hussain, A. Shah, D. Cutler, J. Zhang, and S. Zeuzem. 2007. SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders. Gastroenterology 132:1270-1278.
27. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567.
28. Stryer, L. 1978. Fluorescence energy transfer as a spectroscopic ruler. Annu. Rev. Biochem. 47:819-846.
29. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, and T. J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
30. Xu, X., A. L. Gerard, B. C. Huang, D. C. Anderson, D. G. Payan, and Y. Luo. 1998. Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res. 26:2034-2035.
31. Yi, M., X. Tong, A. Skelton, R. Chase, T. Chen, A. Prongay, S. L. Bogen, A. K. Saksena, F. G. Njoroge, R. L. Veselenak, R. B. Pyles, N. Bourne, B. A. Malcolm, and S. M. Lemon. 2006. Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations. J. Biol. Chem. 281:8205-8215.
32. Zacharias, D. A., J. D. Violin, A. C. Newton, and R. Y. Tsien. 2002. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296:913-916.
33. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102:9294-9299.